What is the recommended treatment with valcyclovir (valacyclovir) for an adult patient with a normal immune system and recurrent herpes simplex virus (HSV) infections?

Valacyclovir for Recurrent Genital Herpes

Episodic Treatment (Treating Active Outbreaks)

For recurrent genital herpes outbreaks, prescribe valacyclovir 500 mg orally twice daily for 3 days, starting at the first sign of prodrome or lesions. 1, 2

Key Prescribing Details:

• Timing is critical: Start treatment during prodrome (tingling, itching) or within 1 day of lesion onset for maximum benefit 1
• Duration: 3 days is equivalent to 5 days in efficacy 3
• Dosing: 500 mg twice daily (12 hours apart) 1, 2
• Can be taken without regard to meals 2

Alternative Episodic Regimens:

• Valacyclovir 500 mg twice daily for 5 days (if you prefer the traditional longer course) 1
• Acyclovir 400 mg three times daily for 5 days 1
• Acyclovir 800 mg twice daily for 5 days 1
• Famciclovir 125 mg twice daily for 5 days 1

Clinical Pearl: The 3-day valacyclovir regimen offers equivalent efficacy to 5-day treatment with improved convenience and compliance 3. Median time to healing is approximately 4-5 days with either regimen 3.

---

Suppressive Therapy (Daily Prevention)

For patients with frequent recurrences (≥6 episodes per year), prescribe valacyclovir 1 gram orally once daily for chronic suppression. 1, 2

Dosing Algorithm Based on Recurrence Frequency:

• <10 recurrences per year: Valacyclovir 500 mg once daily 1, 4
• ≥10 recurrences per year: Valacyclovir 1 gram once daily 1, 4
• HIV-infected patients (CD4+ ≥100): Valacyclovir 500 mg twice daily 1, 2

Alternative Suppressive Regimens:

• Acyclovir 400 mg twice daily 1
• Famciclovir 250 mg twice daily 1

Duration and Monitoring:

• Suppressive therapy reduces recurrence frequency by ≥75% 1, 4
• Safety documented for up to 6 years with acyclovir and 1 year with valacyclovir 1, 2
• After 1 year of continuous therapy, consider discontinuation to reassess recurrence frequency, as it often decreases over time 1
• No laboratory monitoring needed unless significant renal impairment exists 5

---

Critical Prescribing Pitfalls to Avoid

What NOT to Prescribe:

• Never use topical acyclovir - it is substantially less effective than oral therapy 1
• Avoid valacyclovir 8 grams per day - associated with hemolytic uremic syndrome/thrombotic thrombocytopenic purpura in immunocompromised patients 1

When to Suspect Treatment Failure:

• If lesions do not begin to resolve within 7-10 days of therapy, suspect acyclovir resistance 1
• Consider foscarnet 40 mg/kg IV every 8 hours for proven or suspected resistance 1

Special Populations:

• Pregnancy: Routine suppressive therapy is not recommended during pregnancy, though safety data exists for systemic use 1
• Renal impairment: Dose adjustment required based on creatinine clearance 2

---

Patient Counseling Points

• Suppressive therapy reduces but does not eliminate asymptomatic viral shedding or transmission risk 1, 5
• Abstain from sexual activity when lesions or prodromal symptoms are present 1
• Use condoms during all sexual exposures with new or uninfected partners 1
• Inform sex partners about having genital herpes 1
• Antiviral medications control symptoms but do not eradicate the virus or prevent all recurrences 1